LOVFF Cannara Biotech Inc Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
19:23
16 июл
16 июл
Buy Cannara Biotech (LOVFF/LOVE.TO) as 50% capacity expansion (12→18 grow rooms at ~$10M.
Buy Cannara Biotech (LOVFF/LOVE.TO) as 50% capacity expansion (12→18 grow rooms at ~$10M revenue / ~$3-4M EBITDA each) plus a new Curaleaf international distribution deal (~$10M/year high-margin revenue starting next month) could drive ~50% revenue growth within 1-2 years while the stock trades at only ~7x TTM EBITDA; management is accelerating room openings in response to clear demand signals.
Выс.
13:45
29 июн
29 июн
Buy Cannara Biotech (LOVFF/LOVE.TO): company posted its best-ever sales month in May.
Buy Cannara Biotech (LOVFF/LOVE.TO): company posted its best-ever sales month in May, achieved record Ontario market share, business recovered strongly into fiscal Q3 end, competitors are raising prices signaling rational oligopolistic market structure, and Q3 report in two weeks faces low bar vs. management's bullish tone. Fund discloses existing position.
Сред.
Об аналитическом покрытии LOVFF
Buzzberg отслеживает LOVFF (Cannara Biotech Inc) в 1 источниках. Бычьих сигналов: 2, медвежьих: 0, от 1 аналитиков. Сентимент преимущественно бычий (100%). Всего отслеживаются 2 торговые идеи. Последние спикеры: stocks_stones.